https://www.selleckchem.com/products/sar7334.html
[This corrects the article DOI 10.3389/fsurg.2020.594027.].Background To date, there have been few studies examining the efficacy and safety of drug-coated balloon (DC angioplasty in the treatment of Tosaka class III in-stent restenosis (ISR) lesions in the clinical setting. Therefore, this study aimed to investigate the clinical efficacy and safety of DCBs in patients with Tosaka class III ISR femoropopliteal lesions. Methods This single-center study enrolled 28 femoropopliteal ISR Tosaka III patients who were treated by DCB angiopla
Like
Comment
Share
